Similarity of insulin detemir pharmacokinetics, safety, and tolerability profiles in healthy caucasian and Japanese american subjects.
D000293:Adolescent; D000328:Adult; D019540:Area Under Curve; D001213:Asian; D002352:Carrier Proteins / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics*; D000069057:Insulin Detemir; D049528:Insulin, Long-Acting; D016014:Linear Models; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013997:Time Factors; D044465:White People
D002352:Carrier Proteins; D007328:Insulin; D049528:Insulin, Long-Acting; D000069057:Insulin Detemir